Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| APPLIED INDUSTRIAL TECHNOLOGIES INCAIT · Entity 3467 | Director | January 20, 2026 | January 21, 2026 |
| Ingevity CorpNGVT · Entity 4401 | EVP, Chief Financial Officer | March 02, 2026 | March 03, 2026 |
| Magnera CorpMAGN · Entity 5570 | Director | March 09, 2026 | March 10, 2026 |
| QUAKER CHEMICAL CORPKWR · Entity 4278 | SVP, CFO and Treasurer | March 15, 2021 | March 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
APPLIED INDUSTRIAL TECHNOLOGIES INC
Report date January 20, 2026 · Filed January 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,596 |
Reported balance
After 2026-01-20 transaction · row 1
1 source rowRow 1 · 2026-01-20 · Grant · Acquired 572 · Balance 4,596 F1: Shares of restricted stock granted under the 2023 Long-Term Performance Plan that vest one year from the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of restricted stock granted under the 2023 Long-Term Performance Plan that vest one year from the date of the grant.
Ingevity Corp
Report date March 02, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,427 |
Ending reported balance
After 2026-03-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-03-02 · Tax withholding · Disposed 747 · Balance 41,028 F1: Shares withheld by the Company to satisfy tax withholding obligations related to the 2023 RSUs that vested. Row 2 · 2026-03-02 · Tax withholding · Disposed 1,363 · Balance 39,665 F2: Shares withheld by the Company to satisfy tax withholding obligations related to the 2024 RSUs that vested. Row 3 · 2026-03-02 · Tax withholding · Disposed 559 · Balance 39,106 F2: Shares withheld by the Company to satisfy tax withholding obligations related to the 2024 RSUs that vested. Row 4 · 2026-03-02 · Tax withholding · Disposed 1,679 · Balance 37,427 F3: Shares withheld by the Company to satisfy tax withholding obligations related to the 2025 RSUs that vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Company to satisfy tax withholding obligations related to the 2023 RSUs that vested.
F2: Shares withheld by the Company to satisfy tax withholding obligations related to the 2024 RSUs that vested.
F3: Shares withheld by the Company to satisfy tax withholding obligations related to the 2025 RSUs that vested.
Magnera Corp
Report date March 09, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2027-03-09 | Direct | 12,998 |
Reported balance
After 2026-03-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-09 · Grant · Acquired 12,998 · Balance 12,998 F1: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2: This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date.
F2: This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date.
QUAKER CHEMICAL CORP
Report date March 15, 2021 · Filed March 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,977 |
Reported balance
After 2021-03-15 transaction · row 1
1 source rowRow 1 · 2021-03-15 · Grant · Acquired 462 · Balance 3,977 F1: This award represents time-based restricted stock and stock options granted to reporting person for the 2021-2023 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 15, 2024 and the stock options are exercisable in three consecutive annual installments: 553 shares on March 15, 2022; 554 shares on March 15, 2023; and 554 shares on March 15, 2024. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $245.49 · Expires 2028-03-15 | Direct | 1,661 |
Reported balance
After 2021-03-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-03-15 · Grant · Acquired 1,661 · Balance 1,661 F1: This award represents time-based restricted stock and stock options granted to reporting person for the 2021-2023 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 15, 2024 and the stock options are exercisable in three consecutive annual installments: 553 shares on March 15, 2022; 554 shares on March 15, 2023; and 554 shares on March 15, 2024. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) | 56 |
Reported balance
Holding disclosure · report date 2021-03-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 56 |
Filing footnotes · ownership attribution and instrument terms
F1: This award represents time-based restricted stock and stock options granted to reporting person for the 2021-2023 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 15, 2024 and the stock options are exercisable in three consecutive annual installments: 553 shares on March 15, 2022; 554 shares on March 15, 2023; and 554 shares on March 15, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2026 Filed Mar 10, 2026 15:51 UTC | Magnera Corp MAGN · Entity 5570 | GrantRestricted Stock Units · Derivative | 12,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-26-000028 · form4.xml · derivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,998 Underlying: Common Stock, Par Value $.01 · 12,998 shares Expires 2027-03-09 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 20:49 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 1,679 | $71.64 | $120,283.56 |
DisclosureSEC source: 0001659705-26-000002 · wk-form4_1772588984.xml · nonDerivative · entry 4 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,427 F3 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2025 RSUs that vested. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 20:49 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 559 | $71.64 | $40,046.76 |
DisclosureSEC source: 0001659705-26-000002 · wk-form4_1772588984.xml · nonDerivative · entry 3 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,106 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2024 RSUs that vested. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 20:49 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 1,363 | $71.64 | $97,645.32 |
DisclosureSEC source: 0001659705-26-000002 · wk-form4_1772588984.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,665 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2024 RSUs that vested. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 20:49 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 747 | $71.64 | $53,515.08 |
DisclosureSEC source: 0001659705-26-000002 · wk-form4_1772588984.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,028 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2023 RSUs that vested. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 16:55 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 873 | $70.52 | $61,563.96 |
DisclosureSEC source: 0001659705-26-000001 · wk-form4_1772488515.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,775 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the PSUs that vested on February 26, 2026. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 16:55 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 1,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001659705-26-000001 · wk-form4_1772488515.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,648 F1 · shares: The Talent and Compensation Committee of the Company's board of directors certified the attainment of performance goals for certain performance-based restricted stock awards ("PSUs") effective February 26, 2026. The PSUs were settled with shares of common stock. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 21:10 UTC | APPLIED INDUSTRIAL TECHNOLOGIES INC AIT · Entity 3467 | GrantCommon Stock | 572 | $0.00 | $0.00 |
DisclosureSEC source: 0000109563-26-000008 · wk-form4_1769029825.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,596 F1 · shares: Shares of restricted stock granted under the 2023 Long-Term Performance Plan that vest one year from the date of the grant. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:22 UTC | Magnera Corp MAGN · Entity 5570 | GrantRestricted Stock Units · Derivative | 5,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000090 · form4.xml · derivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,871 Underlying: Common Stock, Par Value $.01 · 5,871 shares Expires 2026-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · shares: To align the director equity schedule with the Annual Shareholders Meeting moving forward, this grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the Annual Shareholder Meeting in 2026, at which time directors will be granted a full 2026 Annual Director Award upon their reelection. F3 · derivative.exercise_date: This 2025 Prorated Director Award vests in full one year from the grant date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:33 UTC | Magnera Corp MAGN · Entity 5570 | Exercise / conversionRestricted Stock Units · Derivative | 9,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000064 · form4.xml · derivative · entry 2 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 9,501 shares Expires 2025-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:33 UTC | Magnera Corp MAGN · Entity 5570 | Exercise / conversionCommon Stock, Par Value $.01 | 9,501 | $8.53 | $81,043.53 |
DisclosureSEC source: 0000041719-25-000064 · form4.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 20:40 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 11,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-25-000042 · wk-form4_1741138802.xml · nonDerivative · entry 5 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,868 F4 · shares: Grant of RSUs pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 28, 2026, 2027, and 2028. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 20:40 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 562 | $47.66 | $26,784.92 |
DisclosureSEC source: 0001653477-25-000042 · wk-form4_1741138802.xml · nonDerivative · entry 4 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,760 F3 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2024 RSUs that vested on February 28, 2025. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 20:40 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 1,369 | $47.66 | $65,246.54 |
DisclosureSEC source: 0001653477-25-000042 · wk-form4_1741138802.xml · nonDerivative · entry 3 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,322 F3 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2024 RSUs that vested on February 28, 2025. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 20:40 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 751 | $47.66 | $35,792.66 |
DisclosureSEC source: 0001653477-25-000042 · wk-form4_1741138802.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,691 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2023 RSUs that vested on February 28, 2025. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 20:40 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 452 | $47.66 | $21,542.32 |
DisclosureSEC source: 0001653477-25-000042 · wk-form4_1741138802.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,442 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2022 restricted stock units ("RSUs") that vested on February 28, 2025. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 20:15 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 852 | $48.26 | $41,117.52 |
DisclosureSEC source: 0001653477-25-000028 · wk-form4_1740186911.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,894 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the PSUs that vested on February 19, 2025. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 20:15 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 1,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-25-000028 · wk-form4_1740186911.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,746 F1 · shares: The Talent and Compensation Committee of the Company's board of directors certified the attainment of performance goals for certain performance-based restricted stock awards ("PSUs") effective February 19, 2025. The PSUs were settled with shares of common stock. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:21 UTC | APPLIED INDUSTRIAL TECHNOLOGIES INC AIT · Entity 3467 | GrantCommon Stock | 562 | $0.00 | $0.00 |
DisclosureSEC source: 0000109563-25-000011 · wk-form4_1738012876.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,024 F1 · shares: Shares of restricted stock granted under the 2023 Long-Term Performance Plan that vest one year from the date of the grant. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:15 UTC | APPLIED INDUSTRIAL TECHNOLOGIES INC AIT · Entity 3467 | SaleCommon Stock | 2,200 | $275.08 | $605,167.20 |
DisclosureSEC source: 0000109563-24-000114 · wk-form4_1733174139.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,462 Read SEC document |
| November 04, 2024 Filed Nov 7, 2024 02:05 UTC | Magnera Corp MAGN · Entity 5570 | GrantRestricted Stock Units · Derivative | 9,501 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-026639 · form4.xml · derivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,501 Underlying: Common Stock, Par Value $.01 · 9,501 shares Expires 2025-11-04 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 17:06 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 180 | $44.44 | $7,999.20 |
DisclosureSEC source: 0001653477-24-000041 · form4.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,071 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2021 RSUs that vested on April 19, 2024. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 17:06 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 2,047 | $44.44 | $90,968.68 |
DisclosureSEC source: 0001653477-24-000041 · form4.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,251 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the sign-on RSUs that vested on April 19, 2024. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 17:26 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 3,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-24-000023 · form4.xml · nonDerivative · entry 4 Hall Mary Dean · CIK 0001659705 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,298 F3 · shares: Grant of RSUs pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 28, 2025, 2026, and 2027. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 17:26 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 9,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-24-000023 · form4.xml · nonDerivative · entry 3 Hall Mary Dean · CIK 0001659705 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,601 F3 · shares: Grant of RSUs pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 28, 2025, 2026, and 2027. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 17:26 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 534 | $45.27 | $24,174.18 |
DisclosureSEC source: 0001653477-24-000023 · form4.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,588 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2023 RSUs that vested on February 28, 2024. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 17:26 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 321 | $45.27 | $14,531.67 |
DisclosureSEC source: 0001653477-24-000023 · form4.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,122 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2022 restricted stock units ("RSUs") that vested on February 28, 2024. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 15:27 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 587 | $47.40 | $27,823.80 |
DisclosureSEC source: 0001653477-24-000012 · form4.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,443 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the PSUs that vested on February 22, 2024. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 15:27 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 1,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-24-000012 · form4.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,030 F1 · shares: The Talent and Compensation Committee of the Company's board of directors certified the attainment of performance goals for certain performance-based restricted stock awards ("PSUs") effective February 22, 2024. The PSUs were settled with shares of common stock. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 22:17 UTC | APPLIED INDUSTRIAL TECHNOLOGIES INC AIT · Entity 3467 | GrantCommon Stock | 850 | $0.00 | $0.00 |
DisclosureSEC source: 0000109563-24-000020 · wk-form4_1706221043.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,662 F1 · shares: Shares of restricted stock granted under the 2023 Long-Term Performance Plan that vest one year from the date of the grant. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 16:40 UTC | APPLIED INDUSTRIAL TECHNOLOGIES INC AIT · Entity 3467 | SaleCommon Stock | 2,000 | $153.99 | $307,980.00 |
DisclosureSEC source: 0000109563-23-000107 · wk-form4_1699029620.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,812 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.95 to $154.02, inclusive. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 14:55 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 126 | $71.85 | $9,053.10 |
DisclosureSEC source: 0001653477-23-000014 · form4.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,472 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2021 RSUs that vested on April 19, 2023. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 14:55 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 1,450 | $71.85 | $104,182.50 |
DisclosureSEC source: 0001653477-23-000014 · form4.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,598 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the sign-on RSUs that vested on April 19, 2023. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 15:18 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 4,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-004181 · doc1.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · EVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,048 F2 · shares: Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 28, 2024, 2025, and 2026. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 15:18 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 367 | $82.56 | $30,299.52 |
DisclosureSEC source: 0001567619-23-004181 · doc1.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,106 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2022 RSUs that vested on February 28, 2023. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 14:43 UTC | APPLIED INDUSTRIAL TECHNOLOGIES INC AIT · Entity 3467 | GrantCommon Stock | 1,044 | $0.00 | $0.00 |
DisclosureSEC source: 0000109563-23-000008 · wf-form4_167474421653317.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,812 F1 · shares: Shares of restricted stock granted under the 2019 Long-Term Performance Plan that vest one year from the date of the grant. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 15:34 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 122 | $64.22 | $7,834.84 |
DisclosureSEC source: 0001567619-22-008792 · doc1.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · EVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,473 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2021 RSUs that vested on April 19, 2022. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 15:34 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 3,217 | $64.22 | $206,595.74 |
DisclosureSEC source: 0001567619-22-008792 · doc1.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,595 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the sign-on RSUs that vested on April 19, 2022. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 21:16 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 2,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-005936 · doc1.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,812 F1 · shares: Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 28, 2023, 2024, and 2025. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 12:32 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock · Derivative | 7,315 | $0.00 Strike: $68.23 | $0.00 |
DisclosureSEC source: 0001567619-22-005996 · doc1.xml · derivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,315 Underlying: Common Stock · 7,315 shares Expires 2032-02-28 F1 · derivative.exercise_date: These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably on February 28, 2023, 2024 and 2025. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:04 UTC | APPLIED INDUSTRIAL TECHNOLOGIES INC AIT · Entity 3467 | GrantCommon Stock | 1,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000109563-22-000016 · wf-form4_164322746992015.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,768 F1 · shares: Shares of restricted stock granted under the 2019 Long-Term Performance Plan that vest one year from the date of the grant. Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 16:10 UTC | Ingevity Corp NGVT · Entity 4401 | GrantEmployee Stock Option (right-to-buy) · Derivative | 2,519 | $0.00 Strike: $33.77 | $0.00 |
DisclosureSEC source: 0001653477-21-000028 · wf-form4_161894941857438.xml · derivative · entry 3 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,519 Underlying: Common Stock · 2,519 shares Expires 2031-04-19 F3 · shares: These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning April 19, 2022, 2023 and 2024. Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 16:10 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 1,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-21-000028 · wf-form4_161894941857438.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,822 F2 · shares: Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on April 19, 2022, 2023, and 2024. Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 16:10 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 17,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-21-000028 · wf-form4_161894941857438.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,660 F1 · shares: Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in installments of 50%, 25% and 25% on April 19, 2022, 2023, and 2024, respectively. Read SEC document |
| April 19, 2021 Filed Dec 17, 2021 21:14 UTC Amendment | Ingevity Corp NGVT · Entity 4401 | GrantEmployee Stock Option (right-to-buy) · Derivative | 2,519 | $0.00 Strike: $73.21 | $0.00 |
DisclosureSEC source: 0001493152-21-031946 · form4a.xml · derivative · entry 1 Hall Mary Dean · CIK 0001659705 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,519 Underlying: Common Stock · 2,519 shares Expires 2031-04-19 F1 · derivative.exercise_price: The reporting person's Form 4 filed with the SEC on April 20, 2021 inadvertently reported an incorrect exercise price with respect to the Employee Stock Option (right-to-buy). This amendment is being filed solely to correct the exercise price. F2 · derivative.exercise_date: These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning April 19, 2022, 2023 and 2024. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:28 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantEmployee Stock Option (right to buy) · Derivative | 1,661 | $0.00 Strike: $245.49 | $0.00 |
DisclosureSEC source: 0001209191-21-021341 · doc4.xml · derivative · entry 3 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,661 Underlying: Common Stock · 1,661 shares Expires 2028-03-15 F1 · derivative.exercise_date: This award represents time-based restricted stock and stock options granted to reporting person for the 2021-2023 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 15, 2024 and the stock options are exercisable in three consecutive annual installments: 553 shares on March 15, 2022; 554 shares on March 15, 2023; and 554 shares on March 15, 2024. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:28 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 462 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-021341 · doc4.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,977 F1 · shares: This award represents time-based restricted stock and stock options granted to reporting person for the 2021-2023 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 15, 2024 and the stock options are exercisable in three consecutive annual installments: 553 shares on March 15, 2022; 554 shares on March 15, 2023; and 554 shares on March 15, 2024. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:48 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,490 | $0.00 Strike: $151.75 | $0.00 |
DisclosureSEC source: 0001209191-21-018581 · doc4.xml · derivative · entry 14 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,490 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The options for this grant vested in three annual installments: 830 shares on February 26, 2019; 830 shares on February 26, 2020; and 830 shares on February 26, 2021. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:48 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 248 | $272.83 | $67,661.84 |
DisclosureSEC source: 0001209191-21-018581 · doc4.xml · nonDerivative · entry 12 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,515 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.51 to $273.10, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (10) to this Form 4. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:48 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 102 | $271.60 | $27,703.20 |
DisclosureSEC source: 0001209191-21-018581 · doc4.xml · nonDerivative · entry 11 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.18 to $272.00, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (9) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.